Good compliancea (n = 56) | Poor complianceb (n = 148) | p value | |
---|---|---|---|
Age | |||
Median (RIQ*) | 58 (53.7–60.2) | 59 (54–60) | 0.988 |
Years of menopause | |||
Median (RIQ) | 50 (49–52) | 50 (49–52) | 0.693 |
Sexually active before confinement | |||
Yes | 48 (85.7) | 128 (86.5) | 0.919 |
No | 8 (14.3) | 20 (13.5) | |
Level of education | |||
Basic-medium | 28 (50) | 84 (56.8) | 0.541 |
Higher | 28 (50) | 64 (43.2) | |
Decreased sexual activity | |||
Yes | 12 (21.4) | 100 (67.6) | < 0.001 |
No | 44 (78.6) | 48 (32.4) | |
Indicated treatments | |||
Lubricants, moisturizers | 12 (21.4) | 36 (24.3) | 0.218 |
Local estrogens | 32 (57.1) | 88 (59.5) | |
Prasterone | 4 (7.1) | 16 (10.8) | |
Ospemifene | 8 (14.3) | 4 (2.7) | |
MHT | - | 4 (2,7) | |
COVID infection | |||
Yes | 16 (28.6) | 8 (5.4) | 0.003 |
No | 40 (71.4) | 140 (94.6) |